Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 45 articles:
HTML format
Text format



Single Articles


    June 2017
  1. LAURENZANA A, Chilla A, Luciani C, Peppicelli S, et al
    uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells.
    Int J Cancer. 2017 Jun 2. doi: 10.1002/ijc.30817.
    PubMed     Text format     Abstract available


  2. TU YN, Tong WL, Samy MD, Yavorski JM, et al
    Assessing microenvironment immunogenicity using tumor specimen exomes: Co-detection of TcR-alpha/beta V(D)J recombinations correlates with PD-1 expression.
    Int J Cancer. 2017;140:2568-2576.
    PubMed     Text format     Abstract available


    May 2017
  3. LI X, Liu H, Amos CI, Lee JE, et al
    A PGC1beta genetic variant associated with nevus count and melanoma mortality.
    Int J Cancer. 2017 May 23. doi: 10.1002/ijc.30802.
    PubMed     Text format    


  4. LIU S, Wang Y, Xue W, Liu H, et al
    Genetic Variants in the Genes Encoding Rho GTPases and Related Regulators Predict Cutaneous Melanoma-specific Survival.
    Int J Cancer. 2017 May 16. doi: 10.1002/ijc.30785.
    PubMed     Text format     Abstract available


    March 2017
  5. TANG JQ, Hou XY, Yang CS, Li YX, et al
    Recent developments in nanomedicine for melanoma treatment.
    Int J Cancer. 2017 Mar 24. doi: 10.1002/ijc.30708.
    PubMed     Text format     Abstract available


  6. SILVERSMIT G, Jegou D, Vaes E, Van Hoof E, et al
    Cure of cancer for seven cancer sites in the Flemish Region.
    Int J Cancer. 2017;140:1102-1110.
    PubMed     Text format     Abstract available


    February 2017
  7. CAINI S, Masala G, Saieva C, Kvaskoff M, et al
    Coffee, tea and melanoma risk: findings from the European Prospective Investigation into Cancer and Nutrition.
    Int J Cancer. 2017 Feb 20. doi: 10.1002/ijc.30659.
    PubMed     Text format     Abstract available


  8. DE VRIES E, Amador JR, Rincon CJ, Uribe C, et al
    Cutaneous Melanoma Attributable to Solar Radiation in Cali, Colombia.
    Int J Cancer. 2017 Feb 10. doi: 10.1002/ijc.30638.
    PubMed     Text format     Abstract available


  9. PARK SM, Li T, Wu S, Li WQ, et al
    Niacin intake and risk of skin cancer in US women and men.
    Int J Cancer. 2017 Feb 2. doi: 10.1002/ijc.30630.
    PubMed     Text format     Abstract available


    January 2017
  10. OUDE OPHUIS CM, Louwman MW, Grunhagen DJ, Verhoef C, et al
    Implementation of the 7th Edition AJCC Staging System: Effects on Staging and Survival for pT1 Melanoma. A Dutch Population Based Study.
    Int J Cancer. 2017 Jan 20. doi: 10.1002/ijc.30607.
    PubMed     Text format     Abstract available


  11. POTRONY M, Rebollo-Morell A, Gimenez-Xavier P, Zimmer L, et al
    IRF4 rs12203592 functional variant and melanoma survival.
    Int J Cancer. 2017 Jan 19. doi: 10.1002/ijc.30605.
    PubMed     Text format     Abstract available


  12. SIMOES RL, De-Brito NM, Cunha-Costa H, Morandi V, et al
    Lipoxin A4 selectively programs the profile of M2 tumor-associated macrophages which favour control of tumor progression.
    Int J Cancer. 2017;140:346-357.
    PubMed     Text format     Abstract available


    December 2016
  13. SHEN J, Song R, Wan J, Huff C, et al
    Global methylation of blood leukocyte DNA and risk of melanoma.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30577.
    PubMed     Text format     Abstract available


  14. BAUM C, Weiss C, Gebhardt C, Utikal J, et al
    Sentinel node metastasis mitotic rate (SN-MMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node-positive melanomas.
    Int J Cancer. 2016 Dec 9. doi: 10.1002/ijc.30563.
    PubMed     Text format     Abstract available


  15. LI H, Wang Y, Liu H, Shi Q, et al
    Genetic variants in the integrin signaling pathway genes predict cutaneous melanoma survival.
    Int J Cancer. 2016 Dec 3. doi: 10.1002/ijc.30545.
    PubMed     Text format     Abstract available


    November 2016
  16. LAURILA JP, Laukkanen MO, Joensuu H, Salmi M, et al
    Leukocyte trafficking is not affected by multikinase inhibitors sunitinib or sorafenib in mice.
    Int J Cancer. 2016;139:2270-6.
    PubMed     Text format     Abstract available


  17. HEGEDUS L, Garay T, Molnar E, Varga K, et al
    The plasma membrane Ca2+ pump PMCA4b inhibits the migratory and metastatic activity of BRAF mutant melanoma cells.
    Int J Cancer. 2016 Nov 4. doi: 10.1002/ijc.30503.
    PubMed     Text format     Abstract available


  18. DESCH A, Gebhardt C, Utikal J, Schneider SW, et al
    D-dimers in malignant melanoma: Association with prognosis and dynamic variation in disease progress.
    Int J Cancer. 2016 Nov 3. doi: 10.1002/ijc.30498.
    PubMed     Text format     Abstract available


    September 2016
  19. SARRABAYROUSE G, Pich C, Teiti I, Tilkin-Mariame AF, et al
    Regulatory properties of statins and rho gtpases prenylation inhibitiors to stimulate melanoma immunogenicity and promote anti-melanoma immune response.
    Int J Cancer. 2016 Sep 12. doi: 10.1002/ijc.30422.
    PubMed     Text format     Abstract available


    August 2016
  20. ZHANG W, Liu H, Yin J, Wu W, et al
    Genetic Variants in the PIWI-piRNA Pathway Gene DCP1A Predict Melanoma Disease-specific Survival.
    Int J Cancer. 2016 Aug 31. doi: 10.1002/ijc.30409.
    PubMed     Text format     Abstract available


  21. ROCKBERG J, Amelio JM, Taylor A, Jorgensen L, et al
    Epidemiology of cutaneous melanoma in Sweden - stage specific survival and rate of recurrence.
    Int J Cancer. 2016 Aug 26. doi: 10.1002/ijc.30407.
    PubMed     Text format     Abstract available


    June 2016
  22. VAYSSE A, Fang S, Brossard M, Wei Q, et al
    A comprehensive genome-wide analysis of melanoma Breslow thickness identifies interaction between CDC42 and SCIN genetic variants.
    Int J Cancer. 2016 Jun 27. doi: 10.1002/ijc.30245.
    PubMed     Text format     Abstract available


  23. MAXWELL R, Garzon-Muvdi T, Lipson EJ, Sharfman WH, et al
    BRAF-V600 mutational status affects recurrence patterns of melanoma brain metastasis.
    Int J Cancer. 2016 Jun 25. doi: 10.1002/ijc.30241.
    PubMed     Text format     Abstract available


  24. MIRZAEI H, Naseri G, Rezaee R, Mohammadi M, et al
    Curcumin: A new candidate for melanoma therapy?
    Int J Cancer. 2016 Jun 9. doi: 10.1002/ijc.30224.
    PubMed     Text format     Abstract available


  25. GANDINI S, Ferrucci PF, Botteri E, Tosti G, et al
    Prognostic significance of hematological profiles in melanoma patients.
    Int J Cancer. 2016 Jun 2. doi: 10.1002/ijc.30215.
    PubMed     Text format     Abstract available


    May 2016
  26. ORTEGA-MARTINEZ I, Gardeazabal J, Erramuzpe A, Sanchez-Diez A, et al
    Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I-II early stage melanoma.
    Int J Cancer. 2016 May 23. doi: 10.1002/ijc.30202.
    PubMed     Text format     Abstract available


  27. POTRONY M, Carreras E, Aranda F, Zimmer L, et al
    Inherited functional variants of the lymphocyte receptor CD5 influence melanoma survival.
    Int J Cancer. 2016 May 11. doi: 10.1002/ijc.30184.
    PubMed     Text format     Abstract available


    April 2016
  28. TAYLOR NJ, Thomas NE, Anton-Culver H, Armstrong BK, et al
    Nevus count associations with pigmentary phenotype, histopathological melanoma characteristics and survival from melanoma.
    Int J Cancer. 2016 Apr 22. doi: 10.1002/ijc.30157.
    PubMed     Text format     Abstract available


  29. SMALLEY KS, Fedorenko IV, Kenchappa R, Sahebjam S, et al
    Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy.
    Int J Cancer. 2016 Apr 15. doi: 10.1002/ijc.30147.
    PubMed     Text format     Abstract available


  30. ANDZINSKI L, Kasnitz N, Stahnke S, Wu CF, et al
    Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human.
    Int J Cancer. 2016;138:1982-93.
    PubMed     Text format     Abstract available


    March 2016
  31. SIMBERG-DANELL C, Lyth J, Mansson-Brahme E, Frohm-Nilsson M, et al
    Prognostic factors and disease-specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden.
    Int J Cancer. 2016 Mar 23. doi: 10.1002/ijc.30103.
    PubMed     Text format     Abstract available


  32. ROWE CJ, Tang F, Hughes MC, Rodero MP, et al
    Molecular markers to complement sentinel node status in predicting survival in patients with high risk locally invasive melanoma.
    Int J Cancer. 2016 Mar 14. doi: 10.1002/ijc.30085.
    PubMed     Text format     Abstract available


    February 2016
  33. NAGORE E, Heidenreich B, Rachakonda S, Garcia-Casado Z, et al
    TERT promoter mutations in melanoma survival.
    Int J Cancer. 2016 Feb 13. doi: 10.1002/ijc.30042.
    PubMed     Text format     Abstract available


  34. DEVARAPU SK, Mamidi S, Ploger F, Dill O, et al
    Cytotoxic Activity Against Human Neuroblastoma and Melanoma Cells Mediated by IgM Antibodies Derived from Peripheral Blood of Healthy Donors.
    Int J Cancer. 2016 Feb 2. doi: 10.1002/ijc.30025.
    PubMed     Text format     Abstract available


    January 2016
  35. ERIKSSON H, Lyth J, Andersson TM
    The proportion cured of patients diagnosed with stage III-IV cutaneous malignant melanoma in Sweden 1990-2007: A population-based study.
    Int J Cancer. 2016 Jan 27. doi: 10.1002/ijc.30023.
    PubMed     Text format     Abstract available


    December 2015
  36. OROUJI E, Orouji A, Gaiser T, Larribere L, et al
    MAP Kinase pathway gene copy alterations in NRAS/BRAF wild-type advanced melanoma.
    Int J Cancer. 2015 Dec 18. doi: 10.1002/ijc.29970.
    PubMed     Text format     Abstract available


  37. THOMSEN FB, Folkvaljon Y, Garmo H, Robinson D, et al
    Risk of malignant melanoma in men with prostate cancer. Nationwide, population-based cohort study.
    Int J Cancer. 2015 Dec 14. doi: 10.1002/ijc.29961.
    PubMed     Text format     Abstract available


    September 2015
  38. LERRO CC, Koutros S, Andreotti G, Hines CJ, et al
    Use of acetochlor and cancer incidence in the Agricultural Health Study.
    Int J Cancer. 2015;137:1167-75.
    PubMed     Text format     Abstract available


    August 2015
  39. WISTUBA-HAMPRECHT K, Di Benedetto S, Schilling B, Sucker A, et al
    Phenotypic characterization and prognostic impact of circulating gammadelta and alphabeta T-cells in metastatic malignant melanoma.
    Int J Cancer. 2015 Aug 27. doi: 10.1002/ijc.29818.
    PubMed     Text format     Abstract available


  40. CORREA D, Somoza RA, Lin P, Schiemann WP, et al
    Mesenchymal Stem Cells regulate Melanoma Cancer Cells extravasation to bone and liver at their perivascular niche.
    Int J Cancer. 2015 Aug 1. doi: 10.1002/ijc.29709.
    PubMed     Text format     Abstract available


  41. AL-AHMADY ZS, Scudamore CL, Kostarelos K
    Triggered doxorubicin release in solid tumors from thermosensitive liposome-peptide hybrids: Critical parameters and therapeutic efficacy.
    Int J Cancer. 2015;137:731-43.
    PubMed     Text format     Abstract available


    June 2015
  42. RIBERO S, Davies JR, Glass D, Quaglino P, et al
    RE:RE: High naevus counts confer a favorable prognosis in melanoma patients.
    Int J Cancer. 2015 Jun 24. doi: 10.1002/ijc.29652.
    PubMed     Text format    


  43. AUTIER P, Funck-Brentano E, Aegerter P, Boniol M, et al
    Re: High nevus counts confer a favorable prognosis in melanoma patients by S Ribero and co-workers, published in the International Journal of Cancer, 2015 (Online 21 March 2015).
    Int J Cancer. 2015 Jun 20. doi: 10.1002/ijc.29648.
    PubMed     Text format    


    May 2015
  44. WAGNER NB, Weide B, Reith M, Tarnanidis K, et al
    Diminished levels of the soluble form of RAGE are related to poor survival in malignant melanoma.
    Int J Cancer. 2015 May 27. doi: 10.1002/ijc.29619.
    PubMed     Text format     Abstract available


  45. WALLINGFORD SC, Iannacone MR, Youlden DR, Baade PD, et al
    Comparison of melanoma incidence and trends among youth under 25 years in Australia and England, 1990-2010.
    Int J Cancer. 2015 May 8. doi: 10.1002/ijc.29598.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: